retatrutide patent expiration As the for semaglutide, the key ingredient in the popular weight-loss drug Ozempic, is set to expire in March, Indian pharmaceutical giants are gearing up to flood the market with generic Maximizing GLP-1 Market Exclusivity: Leveraging

Different trip types require different cooling solutions, and understanding these distinctions prevents both over-packing and under-protection

Semaglutide is marketed under three brand names to distinguish different indications and formulations: Ozempic (injectable for diabetes), Wegovy (injectable for obesity), and Rybelsus (oral for diabetes)

[Accessed on 11 June 2026] Q4 2025 / Full Year 2025 Investor Presentation

Ann Transl Med

Wegovy (Semaglutide Injection) For those who prefer alternatives, Wegovy presents a dependable weekly injectable GLP-1 receptor agonist aimed at persistent weight management

These drugs have shown efficacy beyond glycaemic regulation, including significant weight loss, cardiovascular protection, and possible advantages for renal function